BioSpace News Archive

Biotech Beach

OSI Systems’ Optoelectronics and Manufacturing Division Receives $10 Million Order

OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries.

October 23, 2018
·
2 min read
Genetown

XenoTherapeutics Executives Spearhead Initial Hurricane Michael Relief Efforts in Panama City, Florida

Company’s executives arrived on site within 48 hours after the storm hit to deliver medical and emergency supplies to Florida Panhandle residents

October 23, 2018
·
2 min read
Business

Bain Capital and Pfizer Create Cerevel Therapeutics, New CNS Company

Continues Development of Neuroscience Portfolio, Aiming to Bring New Therapies to Patients

October 23, 2018
·
8 min read
Pharm Country

Dr. Jill Biden, National Minority Quality Forum, Global Sponsors and CROs Discuss the Future of Healthcare and Clinical Research at Medidata NEXT NYC 2018

Over 1,000 industry leaders to discuss best practices and the hottest topics in the digital transformation of life sciences

October 23, 2018
·
2 min read
BioCapital

Transamerica Releases Findings on Workplace Wellness Programs

Transamerica announced today the availability of “Impact of Employee Health on Business Success” a research paper that provides analysis and recommendations for creating effective workplace wellness programs.

October 23, 2018
·
4 min read
BioMidwest

Vodori Announces the Pepper Flow Acceleration Program for Emerging Life Science Companies

With the Pepper Flow Acceleration Program, eligible companies can streamline pre-launch promotional review at no cost

October 23, 2018
·
2 min read
FDA

Amneal Announces Approval and Launch of Clobazam Tablets and Clobazam Oral Suspension

U.S market annual sales for the 12 months ended August 2018 for Clobazam Tablets is estimated to be approximately $594 million and for Clobazam oral suspension is estimated to be approximately $255 million.

October 23, 2018
·
7 min read
Business

ATI Announces Third Quarter 2018 Results

Sales were $1.02 billion, 17% higher than Q3 2017 and in line with Q2 2018

October 23, 2018
·
23 min read
Drug Development

Provention Bio Announces Completion of Enrollment of Phase 1b Clinical Trial of PRV-300 in Moderate-to-Severe Ulcerative Colitis

Top-line data from the “PULSE"clinical trial expected in the second quarter of 2019

October 23, 2018
·
4 min read
Lone Star Bio

Virginia Premier Selects Jiva to Help Streamline Workflows and Heighten Efficiencies

Virginia Premier recently selected Jiva 6.1, the end-to-end population health management platform from ZeOmega, to enhance health services for its approximately 220,000 members.

October 23, 2018
·
3 min read